1. Home
  2. TTC vs BMRN Comparison

TTC vs BMRN Comparison

Compare TTC & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Toro Company (The)

TTC

Toro Company (The)

HOLD

Current Price

$91.02

Market Cap

9.3B

ML Signal

HOLD

Logo BioMarin Pharmaceutical Inc.

BMRN

BioMarin Pharmaceutical Inc.

HOLD

Current Price

$53.60

Market Cap

10.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TTC
BMRN
Founded
1914
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Tools/Hardware
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.3B
10.4B
IPO Year
1994
1999

Fundamental Metrics

Financial Performance
Metric
TTC
BMRN
Price
$91.02
$53.60
Analyst Decision
Buy
Buy
Analyst Count
4
18
Target Price
$104.00
$88.22
AVG Volume (30 Days)
579.3K
1.6M
Earning Date
06-04-2026
05-04-2026
Dividend Yield
1.66%
N/A
EPS Growth
N/A
N/A
EPS
0.69
0.54
Revenue
$2,618,650,000.00
$1,313,646,000.00
Revenue This Year
$6.13
$15.02
Revenue Next Year
$4.45
$12.23
P/E Ratio
$137.43
$97.94
Revenue Growth
4.53
17.62
52 Week Low
$67.45
$50.76
52 Week High
$105.19
$66.28

Technical Indicators

Market Signals
Indicator
TTC
BMRN
Relative Strength Index (RSI) 37.12 45.23
Support Level $77.96 $52.06
Resistance Level $97.27 $56.91
Average True Range (ATR) 2.15 1.71
MACD -0.19 0.01
Stochastic Oscillator 15.04 26.03

Price Performance

Historical Comparison
TTC
BMRN

About TTC Toro Company (The)

The Toro Co designs, manufactures, markets, and sells professional turf maintenance equipment and services; turf and agricultural irrigation systems; landscaping equipment and lighting products; snow and ice management equipment; construction equipment; and residential yard and snow thrower products. The company operates through Professional and Residential segments, with the Professional segment serving commercial, agricultural, and construction customers and generating the majority of revenue, while the Residential segment focuses on homeowners. Its products are sold through distributors, dealers, retailers, rental centers, and direct channels, with the United States as its primary revenue-generating market.

About BMRN BioMarin Pharmaceutical Inc.

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.

Share on Social Networks: